Design
Review
Authors
Loading...
May refine CAD risk stratification in nondiabetics; hypothesis-generating for glucose-lowering trials below diabetic thresholds.
Key points are not available for this paper at this time.
Homobono B. Calleja (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: